These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 668390)

  • 21. Liquid-chromatographic study of fluorescent materials in uremic fluids.
    Swan JS; Kragten EY; Veening H
    Clin Chem; 1983 Jun; 29(6):1082-4. PubMed ID: 6851098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromatographic studies of uremic plasma.
    Mamdani BH; Shaykh MM; Evenson MA; Dunea G
    Int J Artif Organs; 1979 Jul; 2(4):187-91. PubMed ID: 88420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of middle molecule compounds.
    Zimmerman L; Jörnvall H; Bergström J; Fürst P; Sjövall J
    Artif Organs; 1981; 4 Suppl():33-6. PubMed ID: 7295092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies on uremic toxins--biochemical analysis of uremic serum (author's transl)].
    Gejyo F
    Nihon Jinzo Gakkai Shi; 1978 Mar; 20(3):199-214. PubMed ID: 353340
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum testosterone levels in experimental acute renal failure.
    Ivić MA; Strahinjić S; Lajsić-Grubor G; Stefanović V
    Exp Clin Endocrinol; 1988 Mar; 92(3):349-56. PubMed ID: 3253109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatomedin inhibitor in uremia.
    Phillips LS; Fusco AC; Unterman TG; del Greco F
    J Clin Endocrinol Metab; 1984 Oct; 59(4):764-72. PubMed ID: 6384255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A comparative study of free amino acid levels in serum and cerebral cortex in uremic rat].
    Kikuchi S; Matsumoto H; Yachi A
    No To Shinkei; 1984 Sep; 36(9):889-93. PubMed ID: 6508956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bound amino acids in serum of patients with chronic renal insufficiency.
    Burzyński S
    Clin Chim Acta; 1969 Aug; 25(2):231-7. PubMed ID: 5801388
    [No Abstract]   [Full Text] [Related]  

  • 29. [Amino acids content in the blood serum of patients with multiple sclerosis].
    Ivanova EM; Barabanova MA; Muzlaev GG; Petropavlovskaia TA; Stoianova OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(6):50-4. PubMed ID: 22983244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of an acidic dipeptide, beta-aspartylglycine, in the CNS of Aplysia.
    McCaman MW; Stetzler J
    J Neurochem; 1984 Nov; 43(5):1375-84. PubMed ID: 6491659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of endogenous middle molecules in normal and uremic body fluids.
    Fürst P; Zimmerman L; Bergström J
    Clin Nephrol; 1976 Apr; 3(2):178-88. PubMed ID: 1277595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The fibroblast growth factor receptor mediates the increased FGF23 expression in acute and chronic uremia.
    Hassan A; Durlacher K; Silver J; Naveh-Many T; Levi R
    Am J Physiol Renal Physiol; 2016 Feb; 310(3):F217-21. PubMed ID: 26311115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma free amino acid levels in uremic rats given high and low protein diets or intravenous infusions of amino acid solutions.
    Kihlberg R; Sterner G; Wennberg A; Denneberg T
    J Nutr; 1982 Nov; 112(11):2058-70. PubMed ID: 6813436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uricosuric agents in uremic sera. Identification of indoxyl sulfata and hippuric acid.
    Boumendil-Podevin EF; Podevin RA; Richet G
    J Clin Invest; 1975 Jun; 55(6):1142-52. PubMed ID: 1133164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Isolation, structure elucidation and synthesis of a hexapeptide from the hemodialysate of uremic patients].
    Bovermann G; Rautenstrauch H; Seybold G; Jung G
    Hoppe Seylers Z Physiol Chem; 1982 Oct; 363(10):1187-202. PubMed ID: 7141402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of beta-aspartylpeptidase activity in human faeces by high-performance liquid chromatography using pre-column derivatization with phenyl isothiocyanate.
    van der Leij FR; Welling GW
    J Chromatogr; 1986 Nov; 383(1):35-42. PubMed ID: 3818845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyroid hormone profiles in experimental acute renal failure.
    Bogićević M; Ilić S; Djordjević V; Ivić M; Koraćević D; Stefanović V
    Ren Fail; 1993; 15(2):173-9. PubMed ID: 8469784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Humoral inhibitors of the immune response in uremia. II. Further characterization of an immunosuppressive factor in uremic serum.
    Raskova J; Morrison AB; Shea SM; Raska K
    Am J Pathol; 1979 Nov; 97(2):277-90. PubMed ID: 230740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversed-phase liquid-chromatographic analysis of hemodialysate from uremic patients.
    Senftleber FC; Halline AG; Veening H; Dayton DA
    Clin Chem; 1976 Sep; 22(9):1522-7. PubMed ID: 8223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.